Print Page  Close Window

Press Releases

Keyword Search
 
Current | Archive
DateTitle 
10/15/14OraSure Technologies Earnings Conference Call Invitation
2014 Third Quarter Earnings Conference Call Wednesday, November 5, 2014, 5:00 p.m. ET BETHLEHEM, Pa., Oct. 15, 2014 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) has scheduled its regular earnings conference call covering 2014 third quarter results and certain 2014 financial guidance for 5:00 pm ET (2:00 pm PT) on Wednesday, November 5, 2014. An update on certain business developments will also be provided.    November 5, 2014 Schedule ... 
Printer Friendly Version
08/14/14Healthy Trucking Association of America, OraSure Technologies and AbbVie Team Up to Launch Hepatitis C Awareness Campaign at The Great American Trucking Show
... 
Printer Friendly Version
08/06/14OraSure Announces 2014 Second Quarter Financial Results
BETHLEHEM, Pa., Aug. 6, 2014 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR), a market leader in oral fluid diagnostics, today announced its consolidated financial results for the three and six months ended June 30, 2014. Financial Highlights Consolidated net revenues for the second quarter of 2014 were $26.4 million, an 8% increase from the comparable quarter of 2013. Consolidated net revenues for the six months ended June 30, 2014 were $49.9 million, a 10% increase fro... 
Printer Friendly Version
08/06/14OraSure Technologies to Present at the Canaccord Genuity 34th Annual Growth Conference
BETHLEHEM, Pa., Aug. 6, 2014 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Canaccord Genuity 34th Annual Growth Conference in Boston, Massachusetts. The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak August 13, 2014, at approximately 11:00 a.m. Eastern Time (08:00 a.m. Pacific Time). Interested investors can access the live w... 
Printer Friendly Version
07/22/14OraSure Technologies Earnings Conference Call Invitation
2014 Second Quarter Earnings Conference Call Wednesday, August 6, 2014, 5:00 p.m. ET BETHLEHEM, Pa., July 22, 2014 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) has scheduled its regular earnings conference call covering 2014 second quarter results and certain 2014 financial guidance for 5:00 pm ET (2:00 pm PT) on Wednesday, August 6, 2014. An update on certain business developments will also be provided. August 6, 2014 Schedule   ... 
Printer Friendly Version
06/26/14OraSure Supports Rapid HIV Testing Initiatives in Recognition of National HIV Testing Day
Company Teams With Ross Mathews, Dr. Rachael Ross and Other Community Voices to Promote HIV Testing With OraQuick(R) BETHLEHEM, Pa., June 26, 2014 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced its support of various rapid HIV testing initiatives and events taking place this week in recognition of National HIV Testing Day, held each year on June 27th. A national campaign occurs on and around National HIV Testing Day each year to raise awareness of the HIV/AIDS epid... 
Printer Friendly Version
06/25/14OraSure Provides Update on Substance Abuse Testing Business
Company Now Projects Net Profit for Second Quarter BETHLEHEM, Pa., June 25, 2014 (GLOBE NEWSWIRE) -- OraSure Technologies (Nasdaq:OSUR), a market leader in point of care diagnostics, announced today continued progress under its agreement with Thermo Fisher Scientific (Thermo Fisher) to develop and supply homogenous fully-automated oral fluid drugs of abuse assays to be used with a new version of the Company's Intercept® oral fluid specimen collection device. The NIDA-5 panel of automated assays... 
Printer Friendly Version
06/17/14OraSure Technologies to Present at the JMP Securities Healthcare Conference
BETHLEHEM, Pa., June 17, 2014 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the JMP Securities Healthcare Conference in New York, New York. The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak June 24, 2014, at approximately 10:30 a.m. Eastern Time (7:30 a.m. Pacific Time). Interested investors can access the live webcast of the pr... 
Printer Friendly Version
06/11/14OraSure Technologies Announces New Co-Promotion Agreement for OraQuick(R) HCV Rapid Antibody Test
Investor Conference Call Scheduled Today for 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time) BETHLEHEM, Pa., June 11, 2014 (GLOBE NEWSWIRE) -- OraSure Technologies (Nasdaq:OSUR), a market leader in point of care diagnostics, announced today that it has entered into a Master Program Services and Co-Promotion Agreement with AbbVie under which AbbVie and OraSure will co-promote the Company's OraQuick® HCV Rapid Test in the United States. The product will be used to test individuals at-risk for hep... 
Printer Friendly Version
06/10/14OraSure Technologies Investor Call Invitation
Investor Conference Call Wednesday, June 11, 2014, 8:30 a.m. ET BETHLEHEM, Pa., June 10, 2014 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) has scheduled an investor conference call and simultaneous webcast for 8:30 a.m. ET (5:30 a.m. PT) on Wednesday, June 11, 2014 to provide an update on certain developments related to its OraQuick® HCV business. June 11, 2014 Schedule 8:20 a.m. ET To participate in the conference call, dial 844-831-3030 (Domestic) or 315-625... 
Printer Friendly Version